ily activate ATM through the oxidation pathway. This may be due to trace amounts of Mn 3+ in preparations of MnCl 2 (30) .
To further investigate the functional effects of the C2991L mutation, we used lymphoblasts from an A-T patient lacking functional ATM and stably complemented these cells with either wildtype or C2991L alleles of ATM under the control of an inducible promoter ( fig. S7 ). After induction, cells were exposed to a low concentration of H 2 O 2 or to camptothecin, a topoisomerase poison that induces DNA breaks. Consistent with the results with purified proteins in vitro, wild-type ATM responded to both H 2 O 2 and camptothecin, whereas the mutant allele only responded to camptothecin treatment (Fig. 4, A and B) . To determine whether these phosphorylation events affected cell survival, we monitored both groups of cells for apoptosis, which is induced by ROS or DNA damage in lymphocytes (31) . The cells expressing wild-type ATM showed a strong apoptotic response to both H 2 O 2 and camptothecin (as measured by a fluorescent caspase 3 substrate assay), whereas cells expressing the mutant allele only underwent caspase activation in response to camptothecin (Fig. 4 , C and D). Confirmation of these results was also obtained by using propidium iodide staining and annexin V to measure cleavage of nuclear DNA and loss of membrane integrity during apoptosis (figs. S8 and S9).
Considering that C2991L and wild-type heterodimers are inactive in vitro (Fig. 3C) , we also overexpressed either the C2991L or a wildtype allele of ATM in cells expressing endogenous wild-type ATM ( fig. S10 ). The cells were treated with bleomycin or H 2 O 2 , and phosphorylation of p53 on Ser 15 and Chk2 on Thr 68 was quantified. Cells overexpressing wild-type ATM showed higher phosphorylation of both p53 and Chk2 in response to H 2 O 2 compared with cells overexpressing C2991L ATM; thus, ectopic expression of the C2991L mutant acted as a dominant negative and inhibited the oxidative activation of wild-type ATM in human cells.
Immortalized lymphoblasts derived from an A-T patient expressing the R3047X ATM allele were also analyzed for responses to H 2 O 2 and DNA damage, which showed that R3047X ATM failed to autophosphorylate ATM or phosphorylate Chk2 after exposure to H 2 O 2 but showed a response to camptothecin that was similar to that seen in cells expressing wild-type ATM (Fig. 4  and fig. S10 ). It is difficult to make quantitative comparisons because the WT and mutant cells were derived from different individuals. The small decrease in responsiveness of the mutant cells to campothecin could mean that the reduced response to H 2 O 2 also reflects a deficit in response to DSBs, but we interpret the result to show a specific deficit in the oxidative response of the R3047X mutant.
We identified and characterized a pathway of ATM activation that is separate from the previously defined pathway that depends on MRN and DNA ends. ATM appears to act as a redox sensor in human cells, and, given the large number of substrates identified as ATM targets after DNA damage (32) , ATM may similarly regulate global cellular responses to oxidative stress. The observation that the R3047X mutation generates an ataxia phenotype in A-T patients but retains normal activation in response to DNA damage suggests that most of the clinical manifestations of A-T may result from an inability to effectively regulate ROS, an observation that has important consequences for A-T treatment strategies. , and enhanced promoter accessibility. Consistently, Pias1 −/− mice displayed an increased natural T reg cell population and were resistant to the development of experimental autoimmune encephalomyelitis. Our studies have identified an epigenetic mechanism that negatively regulates the differentiation of natural T reg cells. N aturally occurring thymus-derived regulatory T (nT reg ) cells play a critical role in the maintenance of self-tolerance and homeostasis within the immune system (1-4). The transcription factor Foxp3 controls the development and function of T reg cells (5-7). Several regulatory DNA elements within the Foxp3 locus have been suggested to modulate Foxp3 expression, including the promoter region and conserved noncoding sequences (6) (7) (8) (9) . Although the transcription factors that positively regulate Foxp3 expression are well characterized (10) (11) (12) (13) , little is known about the negative regulation of Foxp3.
PIAS1 (protein inhibitor of the activated signal transducer and activator of transcription STAT1) is a SUMO E3 ligase that binds to chromatin to repress transcription (14, 15) . The recruitment of PIAS1 to chromatin requires it to be phosphorylated on Ser
90
. This is induced by a variety of immune regulatory stimuli, including TCR (T cell receptor) activation (16) . PIAS1 was phosphorylated on Ser 90 in freshly isolated thymocytes and splenocytes (17) (Fig. 1A ). There was a small increase in the percentage of thymic singlepositive CD4
+ or CD8 + T cells in Pias1 −/− mice, although the total T cell number was not significantly altered (fig. S1, A and B). The frequency of both thymic and splenic CD4 +
Foxp3
+ nT reg cells was significantly increased in Pias1 −/− mice (about 80%) (Fig. 1B) . In addition, the number of thymic CD4 + Foxp3
+ nT reg cells was also significantly increased in Pias1 −/− mice (about 135%) (Fig. 1B) . However, the mean intensity of Foxp3 expression in Foxp3 + cells was not altered in Pias1
−/− cells ( fig. S1C ). Moreover, Pias1 disruption had no significant effect on the in vivo proliferation or survival of T reg cells ( fig. S2 ).
To test whether PIAS1 directly regulates the intrinsic differentiation potential of nT reg cells, bone marrow from wild-type and Pias1
−/− mice depleted of CD4 + and CD8 + T cells was transplanted into sublethally irradiated Rag1 −/− (recombinationactivating gene 1) recipient mice, which lack both T and B cells. Pias1 disruption caused a fourfold ). Experiments in (A) to (D) were performed at least three times (n = 3 to 8 for each experiment). P value was determined by unpaired t test. −/− female mice and their wild-type littermates were immunized with MOG 35-55 and pertussis toxin to induce EAE as described in (17) . The development of EAE was scored (n = 4). (E) Wildtype and Pias1
−/− littermates were immunized as in (D), and lymphocytes were isolated 21 days after the first MOG 35-55 injection and cultured for 3 days in vitro (n = 4). Cytokine production in the cell supernatant was measured by enzyme-linked immunosorbent assay (ELISA). Shown in (A) to (E) is a representative of three independent experiments (n = 3 to 7 for each experiment). Error bars represent SEM. P value was determined by unpaired t test. (Fig. 1C) 
+ differentiation of the CD45.1 + control T cells (Fig. 1D) . These studies suggest that PIAS1 negatively regulates nT reg differentiation.
Peripheral naïve CD4 + T cells can be differentiated into so-called induced T reg cells (iT reg ) (18) (19) (20) . In vitro differentiation studies indicate that transient TCR activation positively regulates iT reg differentiation, whereas persistent TCR stimulation antagonizes Foxp3 induction (21) . Pias1 disruption enhanced iT reg differentiation when naïve CD4 + T cells were transiently stimulated by TCR alone (~70% increase), but not under the persistent TCR activation conditions ( fig. S3A ). In addition, Pias1 disruption resulted in the inhibition of iT reg differentiation when cells were exposed to a prolonged transforming growth factor-b (TGF-b) treatment under the persistent TCR-stimulating conditions ( fig. S3B) 22) (fig. S3C) .
To test the biological significance of PIAS1-mediated regulation of nT reg in vivo, the response of Pias1 −/− mice to myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE) was examined. Ten days after MOG immunization, an increased population of CD4 +
+ T reg cells in the lymph nodes of Pias1 −/− mice was detected, as compared with the wild-type controls (Fig. 2A) . The antigen-specific induction of the proinflammatory cytokines interferon (IFN)-g and interleukin (IL)-17 was significantly suppressed, whereas a higher amount of TGF-b, an immunosuppressive cytokine, was detected in Pias1 −/− lymphocytes ( fig. S4 ). Consistently, intracellular staining assays showed a reduced percentage of antigen-specific IFN-g-or IL-17-producing T cells (Fig. 2B) . Furthermore, a defect in lymphocyte proliferation in response to MOG, but not polyclonal CD3-specific antibody stimulation, was observed in Pias1 −/− mice (Fig.  2C) . The lack of inhibition on Pias1 −/− lymphocyte proliferation in response to polyclonal stimulation is likely due to the hyperproliferation of Pias1 −/− non-T reg lymphocytes under such conditions ( fig. S5 ). The differentiation of T helper T h 1 or T h 17 cells was not defective in vitro in the absence of PIAS1 ( fig. S6 ), which suggests that PIAS1 does not have an intrinsic ability to regulate the differentiation of T h 1 or T h 17 cells.
Pias1
−/− mice displayed resistance toward the development of EAE (Fig. 2D) , and significantly reduced amounts of IFN-g and IL-17, but increased levels of TGF-b, were detected in the lymph nodes of Pias1 −/− mice (Fig. 2E) . These results are consistent with the notion that the increased T reg cells in Pias1 −/− mice contribute to the observed resistance toward the development of EAE.
PIAS1 contains a chromatin-binding domain that targets PIAS1 to gene promoters to regulate transcription (14-16). We tested the hypothesis that Foxp3 may be a direct PIAS1-target gene by ChIP (chromatin immunoprecipitation) assays. PIAS1 bound to the Foxp3 promoter, but not the two conserved noncoding DNA sequences (CNS1 and CNS2), in thymic CD4 + CD8
+ and CD4 + CD25 − T cells (Fig. 3A and fig. S7A ). In contrast, the binding of PIAS1 to the Foxp3 promoter was weak in thymic and peripheral CD4 + cells (6, 7, (23) (24) (25) , which inversely correlates with the amounts of PIAS1 expression − T cells. The data were quantified by QPCR and expressed as a ratio of digestion at the Foxp3 promoter or CNS2 region to digestion at a nondigestible CNS1 region of the Foxp3 locus. Shown in (A) to (D) is a representative of three independent experiments (n = 4 to 6 for each experiment). Error bars represent SEM. P value was determined by unpaired t test. (Fig. 3B and fig.  S8A ). It is noteworthy that Pias1 disruption caused a significant reduction of DNA methylation of the Foxp3 promoter (Fig. 3B and fig. S8A ). In contrast, the removal of PIAS1 showed no effect on the methylation of the heavily methylated CNS2 element ( fig. S8B) , which is consistent with the lack of significant PIAS1 binding to the CNS2 region (Fig. 3A) . Pias1 disruption also showed a modest effect on the demethylation of the Foxp3 promoter in the common lymphoid progenitors and thymic CD4 −
CD8
− cells (fig. S9 ). To examine whether PIAS1 also plays a role in the methylation of other gene promoters, we performed similar studies on CD25, a key regulator of T reg cell differentiation (4, 6) . ChIP studies showed that Cd25 is a PIAS1-target gene ( fig. S10A) fig. S10C) , as well as in transplantation studies ( fig. S10, D and E) .
We also examined the chromatin status of the Foxp3 promoter by analyzing histone modifications. ChIP analysis showed a reduction of the repressive histone H3 methylation at Lys 9 (H3K9) methylation code in Pias1 −/− CD4 + CD8 + thymocytes (Fig. 3C) . In addition, restriction enzyme accessibility analysis (REA) on the Foxp3 locus (23) showed the enhanced accessibility of the Foxp3 promoter, but not the PIAS1 nonbinding CNS2 region in Pias1 −/− thymic CD4 + CD8 + and splenic CD4 + CD25
− T cells (Fig. 3D) , which support a more open chromatin structure of the Foxp3 promoter in Pias1 −/− T cells. Furthermore, Pias1 disruption resulted in the enhanced binding of STAT5, a key transcription factor involved in Foxp3 induction (10) (11) (12) , to the Foxp3 promoter ( fig.  S11A ). The amount of STAT5 protein or STAT5 phosphorylation was not affected by Pias1 disruption ( fig. S11 , B and C). A significant increase of nuclear factor of activated Tcells (NFAT) binding to the Foxp3 promoter was also observed in Pias1
+ thymocytes ( fig. S11D) . Consistently, Pias1 disruption resulted in the increased frequency of Foxp3 + CD4 + CD8 + thymocytes ( fig. S12 ). We examined whether PIAS1 may maintain a repressive chromatin structure through the recruitment of DNA methyltransferases (DNMTs), which promote DNA methylation of chromatin (26) . PIAS1 was shown to interact with DNMT3B in a yeast two-hybrid screen and in 293T cells upon overexpression (27, 28) . DNMT3A and DNMT3B, but not DNMT1, were present in PIAS1 immunoprecipitates from thymocytes or splenic CD4 + CD25
− cells (Fig. 4A) . Furthermore, sequential ChIP studies indicated that PIAS1 forms a complex with DNMT3A and DNMT3B on the Foxp3 gene promoter (Fig. 4B ). DNMT3B and DNMT3A bound to both the Foxp3 promoter and the CNS2 region, but not the CNS1 element, in the wild-type CD4 + CD8
+ thymocytes (Fig. 4C) . Pias1 deletion completely abolished the binding of both DNMT3A and DNMT3B to the Foxp3 promoter (Fig. 4C) , but not the CNS2 region. The levels of DNMT expression were not affected by Pias1 disruption (fig. S13 ). In addition, a modest binding of DNMT1 to the Foxp3 promoter was observed, which was inhibited by − T cells were subjected to immunoprecipitation with PIAS1-specific antibody or IgG, followed by immunoblotting with the indicated antibodies. (B) ChIP assays were performed with wild-type thymocytes by using PIAS1-specific antibody or IgG. The presence of the Foxp3 promoter region in the precipitates was quantified by QPCR. In the re-ChIP experiments, PIAS1-specific antibody precipitates were released, reimmunoprecipitated with an antibody against DNMT3A or DNMT3B, and analyzed for the presence of the Foxp3 promoter sequence. (C) ChIP assays were performed with freshly sorted CD4 + CD8
+ thymocytes from male Pias1 +/+ or Pias1 −/− mice (n = 4), using an antibody against DNMT3A or DNMT3B. Bound DNA was quantified by QPCR with the specific primers against Foxp3 promoter, CNS1 or CNS2 region. (D) Methylation analysis of the Foxp3 promoter was performed by bisulfite conversion of genomic DNA from thymocytes of Rag1 −/− mice reconstituted with either control GFP (Con) or Cre-GFP (Cre) retrovirus-infected Dnmt3a 2lox/2lox / Dnmt3b 2lox/2lox bone marrow. The x axis represents the positions of the CpG sites relative to the transcription start site (+1) in the Foxp3 gene; the y axis represents the percentage. Shown in (A) to (D) is a representative of three independent experiments (n = 4 to 6 for each experiment). Error bars represent SEM. P value was determined by unpaired t test.
Pias1 disruption (fig. S14) mice were infected with green fluorescent protein (GFP) or Cre-GFP retrovirus, and the deletion of Dnmt3a and Dnmt3b was confirmed ( fig. S17A ). Sorted GFP + bone marrow was transplanted into sublethally irradiated Rag1 −/− mice. Decreased Foxp3 promoter methylation was observed in thymocytes from the Rag1 −/− mice reconstituted with the Cre retrovirus-transduced bone marrow (Fig.  4D ). ChIP assays indicated that the decreased DNMT3A and DNMT3B expression by the Cre transduction had no substantial effect on the binding of PIAS1 to the Foxp3 promoter ( fig. S17B ).
Heterochromatin protein 1 (HP1) plays an important role in promoting H3K9 methylation and is known to interact with DNMTs (31). HP1-g was strongly associated with the Foxp3 promoter in wild-type, but not Pias1 −/− , thymocytes ( fig. S18 ). The PIAS1-mediated epigenetic gene regulation is selective, because the chromatin status of genes such as Ctla4 was not affected by Pias1 disruption (fig. S19 ).
Our studies have identified an epigenetic control mechanism in the negative regulation of Foxp3 + nT reg differentiation. PIAS1 acts by maintaining a repressive chromatin state of the Foxp3 promoter, at least partly through the recruitment of DNMTs and HP1 to promote epigenetic modifications ( fig. S20 ). Pias1 disruption results in the formation of a permissive chromatin structure of the Foxp3 promoter and enhanced promoter accessibility to transcription factors such as STAT5 and NFAT, which lead to the increased probability that precursor cells will differentiate into Foxp3 + T reg cells (fig. S20 ). The physiological role of PIAS1 in the regulation of Foxp3 gene is supported by the observed increase of the Foxp3 + nT reg population in Pias1 −/− mice and the resistance of Pias1 −/− mice toward the development of EAE. Thus, the PIAS1 pathway may represent a therapeutic target for the treatment of autoimmune diseases. DNMTs have no intrinsic sequence specificity (26) . Our finding that PIAS1 regulates the binding of DNMTs to the Foxp3 promoter, but not the CNS2 element, suggests that PIAS1 may be an important cofactor that confers specificity in the DNMT-mediated chromatin methylation. The PIAS1-mediated DNA methylation and histone modifications may serve as a fine-tuning mechanism in the control of epigenetic modifications during T cell differentiation.
